TGFB1 and neoplasm: Thus, co-stimulatory αCD28 bispecific antibodies were demonstrated to efficiently counteract immunosuppressive effects of IL-10 and TGF-β on anti-tumor cytotoxic responses as well as on T cell activation, proliferation, cytokine secretion and expansion of central memory effector T cells.